Patents for C07D 249 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms (17,749) |
---|
07/10/2009 | CA2710230A1 Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors |
07/09/2009 | WO2009083457A1 Novel functionalized (meth)acrylic monomers and polymers from acetylenic alcohols |
07/09/2009 | US20090176837 Compounds with activity at retinoic acid receptors |
07/08/2009 | EP1836173A4 Anti-inflammatory medicaments |
07/08/2009 | CN101475538A Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 |
07/08/2009 | CN100509898C Method for dimerisation ispohorone diisolyanate |
07/08/2009 | CN100509773C Alpha -amino-n-hydroxy-acetamide derivatives |
07/07/2009 | US7557244 Substituted biphenyl carboxylic acids and derivatives thereof |
07/07/2009 | CA2438324C Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical |
07/02/2009 | US20090171008 Novel functionalized (METH)acrylic monomers and polymers for acetylenic alcohols |
07/02/2009 | US20090170883 3-arylphenyl sulfide derivative and insecticide and miticide |
07/02/2009 | US20090170881 New inhibitors of histone deacetylase |
07/02/2009 | US20090170874 Triazole-substituted arylamides as P2X3 and P2X2/3 antagonists |
07/02/2009 | US20090170836 New inhibitors of histone deacetylase |
07/02/2009 | US20090170824 Diarylsulfones as 5-HT2A Antagonists |
07/02/2009 | US20090170812 Transcription factor modulating compounds and methods of use thereof |
07/01/2009 | EP1226127B1 Substituted phenyl sulfamoyl carboxamides |
07/01/2009 | CN100506776C NK1 antagonists |
06/30/2009 | US7553972 Benzamide inhibitors of the P2X7 receptor |
06/25/2009 | WO2009079593A1 Piperazinyl derivatives useful as modulators of the neuropeptide y2 receptor |
06/25/2009 | WO2009078587A2 Composition for prevention and treatment of cancer containing triazolyl-thio-ethanone derivatives inhibiting activity of protein phosphatases or pharmaceutically acceptable salts thereof as an active ingredient |
06/25/2009 | WO2009078498A1 Biarylpyrazole 4-carboxamides as cannabinoid cb1 receptor ligands |
06/25/2009 | WO2009078036A2 Process and intermediate of letrozole |
06/25/2009 | WO2009077990A1 Aminotriazole derivatives as alx agonists |
06/25/2009 | WO2009077366A1 Triazole-substituted arylamide derivatives and their use as p2x3 and /or p2x2/3 purinergic receptor antagonists |
06/25/2009 | WO2009076747A1 Viral polymerase inhibitors |
06/25/2009 | US20090162307 Photolatent Systems |
06/25/2009 | US20090160324 Triazole Derivative, Light-Emitting Element, Light-Emitting Device, and Electronic Device |
06/25/2009 | CA2708324A1 Viral polymerase inhibitors |
06/25/2009 | CA2707422A1 Triazole-substituted arylamide derivatives and their use as p2x3 and /or p2x2/3 purinergic receptor antagonists |
06/25/2009 | CA2706839A1 Aminotriazole derivatives as alx agonists |
06/24/2009 | CN100503599C Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
06/23/2009 | US7550601 1-Amino-3-substituted-1,2,3-triazolium salts; quarternary salts are easily converted with appropriate silver salts to wide array of new quarternary salts with various anions, with many of these salts having melting points below 100 C, classifying them as ionic liquids; propellants, agriculture, medicine |
06/23/2009 | US7550489 N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide and phentermine, metformin, or bupropion; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists |
06/18/2009 | WO2009075890A2 Method for synthesis of triazole compounds that modulate hsp90 activity |
06/18/2009 | WO2009075778A2 Nonpeptidic inhibitors of cruzain |
06/18/2009 | WO2009075080A1 Fluoroalkylsulfide derivative and pest control agent |
06/18/2009 | WO2009046841A3 Piperidine and piperazine derivatives for treating tumours |
06/17/2009 | EP1611088B1 Hydroxamates as therapeutic agents |
06/17/2009 | EP1542990B1 Novel imidazole compounds as transforming growth factor (tgf) inhibitors |
06/17/2009 | CN100502087C 场致发光器件 Electroluminescent device |
06/16/2009 | US7547802 Compounds for the treatment of metabolic disorders |
06/11/2009 | WO2009070873A1 Substituted 2-naphthoic acids as antagonists of gpr105 activity |
06/11/2009 | WO2007083320A3 Conversion of aromatic diazonium salt to aryl hydrazine |
06/11/2009 | US20090149444 Benzylamine analogues |
06/11/2009 | CA2706632A1 Substituted 2-naphthoic acids as antagonists of gpr105 activity |
06/10/2009 | EP2066646A1 Process for the preparation of pure anastrozole |
06/10/2009 | EP2066632A1 Benzophenone derivatives useful for inhibiting formation of microtubule |
06/10/2009 | CN101450934A Sulfonyl-derivatives as novel inhibitors of histone deacetylase |
06/10/2009 | CN101450932A Amide-containing triazoles compounds, preparation method, application thereof and composition containing the same |
06/10/2009 | CN101450931A Tert-butyl-containing triazoles compounds, preparation method, application thereof and composition containing the same |
06/10/2009 | CN100497319C Rectifying method for methyl benzotrizole |
06/09/2009 | US7544738 Method for the preparation of 1-benzotriazolyl carbonate esters of poly(ethylene glycol) |
06/04/2009 | WO2009070740A2 Novel compounds and compositions and methods of use |
06/04/2009 | WO2009069312A1 Aryl (1h-1,2,4-triazol-1-yl) compound, and process for production thereof |
06/04/2009 | WO2009069140A1 An improved process for preparation of letrozole and its intermediates |
06/04/2009 | US20090143370 Non-nucleoside Reverse Transcriptase Inhibitors |
06/04/2009 | US20090142347 Tissue-Nonspecific Alkaline Phosphatase (TNAP): a Therapeutic Target for Arterial Calcification |
06/04/2009 | CA2706858A1 Imidazole and triazole derivatives and methods of use |
06/03/2009 | EP2065370A1 2-cyanobenzene sulfonamides as pesticides |
06/03/2009 | EP2065369A1 Urea compound or salt thereof |
06/03/2009 | CN101448798A Compounds and methods for modulating FXR |
06/03/2009 | CN101448797A Heterocyclic type cinnamide derivative |
06/03/2009 | CN101445489A 1-azolyl-2-arylpropyl-2-ol, preparation method and application thereof |
06/03/2009 | CN101445488A Triazoles compounds with antimicrobial activity and preparation method and pharmaceutical use thereof |
06/03/2009 | CN101444496A Compounds for the treatment of metabolic disorders |
06/02/2009 | US7541375 Azole derivatives and pharmaceutical compositions containing them |
06/02/2009 | US7541374 Malononitrile compounds and use thereof |
06/02/2009 | US7541369 Amino-derivatives as novel inhibitors of histone deacetylase |
06/02/2009 | US7541096 Blue emitting, durable, organoelectrouminescent layers containing 2H-benzotriazole compounds; full color display panels; light emission efficiency and brightness |
05/28/2009 | WO2009067663A1 Alkynes and methods of reacting alkynes with 1,3-dipole-functional compounds |
05/28/2009 | WO2009066060A2 4-substituted-6-isopropyl-benzene-1,3-diol compounds and their use |
05/28/2009 | WO2009049180A3 Heteroaryl amides useful as inhibitors of voltage-gated sodium channels |
05/28/2009 | US20090137585 N-acylsulfonamide apoptosis promoters |
05/28/2009 | US20090137021 Anti-inflammatory medicaments |
05/27/2009 | EP2061760A1 Benzo-fused compounds for use in treating metabolic disorders |
05/27/2009 | EP0934287B1 Heterocyclic esters and amides |
05/27/2009 | CN101443346A Hybrid compounds based on polyol(s) and at least one other molecular entity, polymer or otherwise, especially of the polyorganosiloxane type, method for the preparation thereof, and applications of th |
05/27/2009 | CN101443003A Triazole derivatives II |
05/27/2009 | CN101440068A Preparation of 4-(4-ethoxycarbonyl-1,2,3-triazole) phenylacetylene |
05/27/2009 | CN100491356C Compounds exhibiting thrombopoietin receptor agaonism |
05/27/2009 | CN100491319C Process for producing epoxytriazole compound and intermediate therefor |
05/26/2009 | US7538230 Reacting 1,2,4 triazole with activated bis-(4-cyanophenyl)-methane to give letrazole, the activated bis-(4-cyanophenyl)-methane comprises a leaving groups like hydroxy halogens and sulfonates; The impurity isoletrozole is oxidized to 4,4'- dicyanobenzophenone, which then seperated by crystallization |
05/26/2009 | US7538215 Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
05/26/2009 | CA2344058C Diaminopropionic acid derivatives |
05/21/2009 | US20090131673 Electroluminescent Device |
05/21/2009 | US20090131438 Triazole derivative |
05/21/2009 | US20090131419 Which modulates activity of amyloid precursor proteins; Alzheimer's disease |
05/20/2009 | CN101434583A Phenyl bis (benzotriazol) dicarboxylate compound |
05/20/2009 | CN101434582A Phenyl (benzotriazolyl) benzoate compound |
05/19/2009 | US7534814 Mutilin derivatives and their use as antibacterials |
05/19/2009 | CA2498047C Novel imidazole compounds as transforming growth factor (tgf) inhibitors |
05/14/2009 | WO2009061652A1 Compounds which modulate the cb2 receptor |
05/14/2009 | WO2009060053A1 1, 2, 3-triazole derivatives for use as stearoyl-coa desaturase inhibitors |
05/14/2009 | US20090124669 Structural Analogues of Avenanthramides, Their Use in Compositions Useful in the Treatment of Dermatological Disorders |
05/14/2009 | US20090123372 radioactively labeled high affinity CA-IX ligands that identify enzymatic activity of cell-surface expressed carbonic anhydrase-IX (CA-IX), a protein over expressed in patients in with tumor growth; sulfonamide compounds useful for in vivo positron emission tomography for the diagnosis of cancer |
05/14/2009 | CA2705113A1 1, 2, 3-triazole derivatives for use as stearoyl-coa desaturase inhibitors |
05/14/2009 | CA2704684A1 Compounds which modulate the cb2 receptor |
05/13/2009 | EP1587795B1 N- (1-benzyl-2-oxo-2- (1-piperazinyl) ethyl) -1-piperidincarboxamid-derivatives and related compounds use as cgrp-antagonists for treating a headache |
05/13/2009 | CN101429168A Method for preparation of bactericide of flutriafol |